Dr Reddys Laboratories Ltd.

BSE: 500124 | NSE: DRREDDY |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category

Series: EQ | ISIN: INE089A01031 | SECTOR: Pharmaceuticals & DrugsPharmaceuticals & Drugs

Success

Alert

Please select a Day.

Info

Open trading A/c Open trading A/c

Dr Reddys Labo Dr Reddys Laboratories Ltd. | BSE 1234.55 5.30 (0.43%) | NSE 1234.90 5.30 (0.43%) | Trade | Add

BSE Live

Nov 13, 16:01

1234.55 5.30 (0.43%)

Volume

AVERAGE VOLUME

5-Day

30,526

10-Day

87,478

30-Day

229,763

33,002

Prev. Close

1229.25
Open Price

1241.75

Bid Price (Qty.)
1232.00 (6)
Offer Price (Qty.)
1242.00 (40)

NSE Live

Nov 13, 15:55

1234.90 5.30 (0.43%)

Volume

AVERAGE VOLUME

5-Day

1,651,411

10-Day

2,551,412

30-Day

2,108,791

1,426,984

Prev. Close

1229.60
Open Price

1235.80

Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
1234.90 (73)

Financials

Print/Copy to Excel : Go

Profit & Loss account of Dr Reddys Laboratories (in Rs. Cr.)	Mar 20	Mar 19	Mar 18	Mar 17	Mar 16
	12 mths	12 mths	12 mths	12 mths	12 mths
INCOME
Revenue From Operations [Gross]	11,803.00	10,572.90	9,302.60	9,628.10	10,234.80
Less: Excise/Sevice Tax/Other Levies	0.00	0.00	0.00	0.00	84.20
Revenue From Operations [Net]	11,803.00	10,572.90	9,302.60	9,628.10	10,150.60
Total Operating Revenues	11,850.40	10,625.50	9,359.30	9,719.80	10,207.70
Other Income	743.20	238.40	204.00	591.20	244.80
Total Revenue	12,593.60	10,863.90	9,563.30	10,311.00	10,452.50
EXPENSES
Cost Of Materials Consumed	2,556.50	2,103.20	2,011.00	1,904.60	1,988.50
Purchase Of Stock-In Trade	1,117.20	868.60	671.60	671.50	610.40
Operating And Direct Expenses	0.00	0.00	0.00	0.00	94.20
Changes In Inventories Of FG,WIP And Stock-In Trade	-99.90	66.00	-51.60	1.90	-28.80
Employee Benefit Expenses	2,030.20	1,931.90	1,843.00	1,803.30	1,710.00
Finance Costs	47.80	56.80	62.80	57.20	63.80
Depreciation And Amortisation Expenses	789.20	780.60	774.10	735.10	649.10
Other Expenses	3,376.80	3,356.10	3,555.40	3,592.90	3,429.40
Total Expenses	9,817.80	9,163.20	8,866.30	8,766.50	8,516.60
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax	2,775.80	1,700.70	697.00	1,544.50	1,935.90
Exceptional Items	0.00	0.00	0.00	0.00	-355.90
Profit/Loss Before Tax	2,775.80	1,700.70	697.00	1,544.50	1,580.00
Tax Expenses-Continued Operations
Current Tax	483.90	281.80	138.10	182.60	416.00
Less: MAT Credit Entitlement	0.00	0.00	0.00	0.00	97.00
Deferred Tax	-645.80	141.60	-8.00	-22.20	-93.50
Tax For Earlier Years	0.00	0.00	0.00	0.00	0.00
Total Tax Expenses	-161.90	423.40	130.10	160.40	225.50
Profit/Loss After Tax And Before ExtraOrdinary Items	2,937.70	1,277.30	566.90	1,384.10	1,354.50
Profit/Loss From Continuing Operations	2,937.70	1,277.30	566.90	1,384.10	1,354.50
Profit/Loss For The Period	2,937.70	1,277.30	566.90	1,384.10	1,354.50
OTHER ADDITIONAL INFORMATION
EARNINGS PER SHARE
Basic EPS (Rs.)	177.23	76.98	34.19	83.05	79.42
Diluted EPS (Rs.)	176.88	76.85	34.12	82.88	79.14
VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS
Imported Raw Materials	0.00	0.00	0.00	0.00	766.80
Indigenous Raw Materials	0.00	0.00	0.00	0.00	1,221.70
STORES, SPARES AND LOOSE TOOLS
Imported Stores And Spares	0.00	0.00	0.00	0.00	107.00
Indigenous Stores And Spares	0.00	0.00	0.00	0.00	322.10
DIVIDEND AND DIVIDEND PERCENTAGE
Equity Share Dividend	391.40	332.00	399.20	335.30	340.50
Tax On Dividend	0.00	68.20	0.00	0.00	69.30
Equity Dividend Rate (%)	500.00	400.00	400.00	400.00	400.00